Evidence map›Paper›PMID 37442977›Full record

ArticleBMC genomics2023

iEnhancer-DCSA: identifying enhancers via dual-scale convolution and spatial attention.

Wenjun Wang, Qingyao Wu, Chunshan Li

Abstract read
In one paragraph

Article in BMC genomics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Wenjun WangSchool of Software Engineering, South China University of Technology, Guangzhou, China.
Qingyao WuSchool of Software Engineering, South China University of Technology, Guangzhou, China. qyw@scut.edu.cn.
Chunshan LiDepartment of Computer Science and Technology, Harbin Institute of Technology, Weihai, China. lics@hit.edu.cn.

Funding

2022 Tencent Wechat Rhino-Bird Focused Research Program Tencent WeChat RBFR2022008Major Key Project of PCL PCL2021A09National Natural Science Foundation of China 62272172 and 61876208Tip-top Scientific and Technical Innovative Youth Talents of Guangdong Special Support Program 2019TQ05X200
6 · The paper itself

Abstract

backgroundDue to the dynamic nature of enhancers, identifying enhancers and their strength are major bioinformatics challenges. With the development of deep learning, several models have facilitated enhancers detection in recent years. However, existing studies either neglect different length motifs information or treat the features at all spatial locations equally. How to effectively use multi-scale motifs information while ignoring irrelevant information is a question worthy of serious consideration. In this paper, we propose an accurate and stable predictor iEnhancer-DCSA, mainly composed of dual-scale fusion and spatial attention, automatically extracting features of different length motifs and selectively focusing on the important features.

resultsOur experimental results demonstrate that iEnhancer-DCSA is remarkably superior to existing state-of-the-art methods on the test dataset. Especially, the accuracy and MCC of enhancer identification are improved by 3.45% and 9.41%, respectively. Meanwhile, the accuracy and MCC of enhancer classification are improved by 7.65% and 18.1%, respectively. Furthermore, we conduct ablation studies to demonstrate the effectiveness of dual-scale fusion and spatial attention.

conclusionsiEnhancer-DCSA will be a valuable computational tool in identifying and classifying enhancers, especially for those not included in the training dataset.

Indexed as

Computational BiologyEnhancer Elements, GeneticDual-scale convolutionEnhancersSpatial attentionWord embedding

Identifiers

PMID37442977
PMCPMC10339552

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.